In the title molecule, the pyrazolopyrimidine moiety is planar with the methylsulfanyl substituent lying essentially in the same plane, whereas the benzyl group is rotated well out of this plane giving the molecule an approximate L shape.
Keywords: crystal structure, pyrazolopyrimidine, sulfide, hydrogen bond, C—H⋯π(ring) interaction
Abstract
The pyrazolopyrimidine moiety in the title molecule, C13H12N4S, is planar with the methylsulfanyl substituent lying essentially in the same plane. The benzyl group is rotated well out of this plane by 73.64 (6)°, giving the molecule an approximate L shape. In the crystal, C—H⋯π(ring) interactions and C—H⋯S hydrogen bonds form tubes extending along the a axis. Furthermore, there are π–π interactions between parallel phenyl rings with centroid-to-centroid distances of 3.8418 (12) Å. A Hirshfeld surface analysis of the crystal structure indicates that the most important contributions to the crystal packing are from H⋯H (47.0%), H⋯N/N⋯H (17.6%) and H⋯C/C⋯H (17.0%) interactions. The volume of the crystal voids and the percentage of free space were calculated to be 76.45 Å3 and 6.39%, showing that there is no large cavity in the crystal packing. Evaluation of the electrostatic, dispersion and total energy frameworks indicate that the cohesion of the crystal structure is dominated by the dispersion energy contributions.
1. Chemical context
The chemistry of heterocyclic compounds has attracted increasing interest in recent decades, driven by the therapeutic potential of many of these compounds, particularly those containing nitrogen. Notably, nitrogen heterocycles have emerged as promising candidates for bioactive molecules (Irrou et al., 2022 ▸; Sebbar et al., 2016 ▸). Among these, pyrazolo[3,4-d]pyrimidine stands out as an important compound, with its derivatives exhibiting various pharmacological properties (Severina et al., 2016 ▸). They are widely used in pharmaceutical research for their anti-tumour (Kandeel et al., 2012 ▸), anti-inflammatory (El-Tombary, 2013 ▸), antimicrobial (Bakavoli et al., 2010 ▸), antioxidant (El-Mekabaty, 2015 ▸), anticonvulsant (Severina et al., 2016 ▸) and anticancer (Maher et al., 2019 ▸) properties. Additionally, pyrazolopyrimidines have been shown to treat Alzheimer’s disease (Zhang et al., 2018 ▸), human leukaemia (HL-60) (Song et al., 2011 ▸) and exert potent activity against viruses of herpes (Gudmundsson et al., 2009 ▸).
Continuing our research in this area, we synthesized the title compound, 1-benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine, (I), and carried out its crystal-structure determination, as well as analyses of the Hirshfeld surface, crystal voids, intermolecular interaction energies and energy frameworks.
2. Structural commentary
The pyrazolopyrimidine moiety of (I) is essentially planar (root-mean-square deviation = 0.0046 Å), and the C7–C12 phenyl ring is inclined to this plane by 73.64 (6)°, giving the molecule an approximate L shape (Fig. 1 ▸). The methylsulfanyl substituent lies in the mean plane of the pyrazolopyrimidine moiety, as indicated by the N1—C1—S1—C13 torsion angle of −0.32 (18)°. All bond lengths and angles in this molecule appear to be characteristic.
Figure 1.
The molecular structure of (I) with the labelling scheme and displacement ellipsoids drawn at the 50% probability level.
3. Supramolecular features
In the crystal of (I), inversion dimers are formed by C13—H13C⋯Cg3ii interactions (Cg3 is the centroid of the C7–C12 phenyl ring). Through additional C—H⋯S hydrogen bonds, the dimers are connected into rectangular tubes extending parallel to the a axis (Table 1 ▸, Fig. 2 ▸). The tubes are stacked along the c axis by van der Waals contacts between them (Fig. 3 ▸). Furthermore, there are Cg3–Cg3i interactions between parallel phenyl rings with a centroid-to-centroid distances of 3.8418 (12) Å [α = 0.03 (10)°; symmetry code: (i) −x, −y, 1 − z].
Table 1. Hydrogen-bond geometry (Å, °).
Cg3 is the centroid of the C7–C12 phenyl ring.
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| C2—H2⋯S1i | 0.97 (3) | 2.81 (3) | 3.781 (2) | 174 (2) |
| C13—H13C⋯Cg3ii | 1.02 (4) | 2.49 (4) | 3.455 (2) | 157 (3) |
Symmetry codes: (i)
; (ii)
.
Figure 2.
Detail of a portion of one tube with C—H⋯S hydrogen-bonding interactions and C—H⋯π(ring) interactions shown, respectively, by purple and green dashed lines.
Figure 3.
Packing giving an end view of three tubes seen along the b axis with C—H⋯π(ring) interactions shown as dashed lines.
4. Hirshfeld surface analysis
In order to visualize the intermolecular interactions in the crystal of (I), a Hirshfeld surface (HS) analysis (Hirshfeld, 1977 ▸; Spackman & Jayatilaka, 2009 ▸) was carried out by using CrystalExplorer (Spackman et al., 2021 ▸). In the HS plotted over dnorm (Fig. 4 ▸), the white surface indicates contacts with distances equal to the sum of van der Waals radii, and the red and blue areas indicate distances shorter (in close contact) or longer (distant contact) than the van der Waals radii, respectively (Venkatesan et al., 2016 ▸). The bright-red spots indicate their roles as the respective donors and/or acceptors; they also appear as blue and red regions corresponding to positive and negative potentials on the HS mapped over electrostatic potential (Spackman et al., 2008 ▸; Jayatilaka et al., 2005 ▸), as shown in Fig. 5 ▸. The blue regions indicate positive electrostatic potential (hydrogen-bond donors), while the red regions indicate negative electrostatic potential (hydrogen-bond acceptors). The π–π stacking and C—H⋯π interactions were further visualized by the shape-index surface. This surface can be used to identify characteristic packing modes, in particular, planar stacking arrangements and the presence of aromatic stacking interactions. In this regard, the shape-index represents the C—H⋯π interactions as ‘red p-holes’, which are related to the electron ring interactions between the CH groups with the centroid of the aromatic rings of neighbouring molecules. Fig. 6 ▸a clearly suggests that there are C—H⋯π interactions in (I), and π–π stacking is indicated by the presence of adjacent red and blue triangles (Fig. 6 ▸b).
Figure 4.
View of the three-dimensional Hirshfeld surface of the title compound plotted over dnorm.
Figure 5.
View of the three-dimensional Hirshfeld surface of the title compound plotted over electrostatic potential energy using the STO-3 G basis set at the Hartree–Fock level of theory. Hydrogen-bond donors and acceptors are shown as blue and red regions around the atoms corresponding to positive and negative potentials, respectively.
Figure 6.
Hirshfeld surface of the title compound plotted over shape-index for two orientations.
The overall two-dimensional fingerprint plot, Fig. 7 ▸a, and those delineated into H⋯H, H⋯N/N⋯H, H⋯C/C⋯H, H⋯S/S⋯H, C⋯C, C⋯S/S⋯C, N⋯S/S⋯N, C⋯N/N⋯C and N⋯N contacts (McKinnon et al., 2007 ▸) are illustrated in Fig. 7 ▸b–j, respectively, together with their relative contributions to the Hirshfeld surface. The most important interaction is H⋯H, contributing 47.0% to the overall crystal packing, which is reflected in Fig. 7 ▸b as widely scattered points of high density due to the large hydrogen content of the molecule with the tip at de = di = 1.20 Å. The symmetrical pair of spikes resulting in the fingerprint plot delineated into H⋯N/N⋯H contacts (Fig. 7 ▸c) with a 17.6% contribution to the HS has the tips at de + di = 2.52 Å. In the presence of C—H⋯π interactions (Table 1 ▸, Fig. 6 ▸), the H⋯C/C⋯H contacts, contributing 17.0% to the overall crystal packing, are reflected in Fig. 7 ▸d with the tips at de + di = 2.73 Å. The H⋯S/S⋯H contacts (Fig. 7 ▸e) contribute 5.6% to the HS, and their symmetrical pair of spikes has the tips at de + di = 2.68 Å. The C⋯C contacts (Fig. 7 ▸f) have an arrow-shaped distribution of points, contributing 4.7% to the HS, with the tip at de = di = 1.68 Å. The symmetrical pairs of C⋯S/S⋯C (Fig. 7 ▸g) and N⋯S/S⋯N (Fig. 7 ▸h) contacts contribute 3.7% and 2.4% to the HS, and they are observed with the tips at de + di = 3.58 Å and de + di = 3.61 Å, respectively. Finally, the C⋯N/N⋯C (Fig. 7 ▸i) and N⋯N (Fig. 7 ▸j) contacts, with 1.7% and 0.2% contributions to the HS, have very low abundance.
Figure 7.
The full two-dimensional fingerprint plots for the title compound, showing (a) all interactions, and delineated into (b) H⋯H, (c) H⋯N/N⋯H, (d) H⋯C/C⋯H (e) H⋯S/S⋯H, (f) C⋯C, (g) C⋯S/S⋯C, (h) N⋯S/S⋯N, (i) C⋯N/N⋯C and (j) N⋯N interactions. The di and de values are the closest internal and external distances (in Å) from given points on the Hirshfeld surface.
The nearest neighbour environment of a molecule can be determined from the colour patches on the HS based on how close to other molecules they are. The Hirshfeld surface representations with the function dnorm plotted onto the surface are shown for the H⋯H, H⋯N/N⋯H and H⋯C/C⋯H interactions in Fig. 8 ▸a–c, respectively. The Hirshfeld surface analysis confirms the importance of H-atom contacts in establishing the packing. The large number of H⋯H, H⋯N/N⋯H and H⋯C/C⋯H interactions suggest that van der Waals interactions and hydrogen bonding play the major roles in the crystal packing (Hathwar et al., 2015 ▸).
Figure 8.
The Hirshfeld surface representations with the fragment patch plotted onto the surface for (a) H⋯H, (b) H⋯N/N⋯H and (c) H⋯C/C⋯H interactions.
5. Crystal voids
The strength of the crystal packing is important for determining the response to an applied mechanical force. For checking the mechanical stability of the crystal, a void analysis was performed by adding up the electron densities of the spherically symmetric atoms comprised in the asymmetric unit (Turner et al., 2011 ▸). The void surface is defined as an isosurface of the procrystal electron density and is calculated for the whole unit cell where the void surface meets the boundary of the unit cell and capping faces are generated to create an enclosed volume. The volume of the crystal voids (Fig. 9 ▸a,b) and the percentage of free space in the unit cell are calculated as 76.45 Å3 and 6.39%, respectively. Thus, the crystal packing appears compact and the mechanical stability should be substantial.
Figure 9.
Graphical views of voids in the crystal packing of (I) (a) along the a axis and (b) along the b axis. The grey shaded areas represent the filled regions (electron densities), while the colourless regions represent the crystal voids (free spaces).
6. Interaction energy calculations and energy frameworks
The intermolecular interaction energies were calculated using the CE–B3LYP/6–31G(d,p) energy model available in CrystalExplorer (Spackman et al., 2021 ▸), where a cluster of molecules is generated by applying crystallographic symmetry operations with respect to a selected central molecule within the radius of 3.8 Å by default (Turner et al., 2014 ▸). The total intermolecular energy (Etot) is the sum of electrostatic (Eele), polarization (Epol), dispersion (Edis) and exchange-repulsion (Erep) energies (Turner et al., 2015 ▸) with scale factors of 1.057, 0.740, 0.871 and 0.618, respectively (Mackenzie et al., 2017 ▸). Hydrogen-bonding interaction energies (in kJ mol−1) were calculated to be −30.3(Eele), −3.6 (Epol), −74.7 (Edis), 70.9 (Erep) and −55.9 (Etot) for the C2—H2⋯S1 hydrogen-bonding interaction. Energy frameworks combine the calculation of intermolecular interaction energies with a graphical representation of their magnitude (Turner et al., 2015 ▸). Energies between molecular pairs are represented as cylinders joining the centroids of pairs of molecules with the cylinder radius proportional to the relative strength of the corresponding interaction energy. Energy frameworks were constructed for Eele (red cylinders) and Edis (green cylinders) (Fig. 10 ▸a,b). The evaluation of the electrostatic, dispersion and total energy frameworks indicate that the stabilization is dominated via the dispersion energy contributions in the crystal structure of (I).
Figure 10.
The energy frameworks for a cluster of molecules of (I) viewed down the c axis showing (a) electrostatic energy and (b) dispersion energy diagrams. The cylindrical radius is proportional to the relative strength of the corresponding energies and they were adjusted to the same scale factor of 80 with cut-off value of 5 kJ mol−1 within 2×2×2 unit cells.
7. Database survey
A search of the Cambridge Structural Database (CSD, updated to March 2024; Groom et al., 2016 ▸) using the search fragment detailed in Fig. 11 ▸ (R = C—CH, C—C—OH; R1 = R2 = nothing) identified eleven relevant hits. These structures include R = t-Bu, R2 = H, R1 = Ph (RULHEN; Liu et al., 2015 ▸), p-anis (QIBVIH; Tan et al., 2007 ▸); R2 = H, R = i-Pr, R1 = cyclobutanecarboxamido (QIBVON; Tan et al., 2007 ▸), R = n-Bu, R1 = benzamido (QIBWAA; Tan et al., 2007 ▸), R = 3-phenylpropyl, R1= CH3S (IFICUV; Avasthi et al., 2002 ▸), R = 2-chloroethyl, R1= H (XAZRAT; Khazi et al., 2012 ▸); R = 1-β-d-ribofuranosyl, R1 = H, R2 = OMe (FOVHIH; Anderson et al., 1986 ▸), R1= NH2, R" = H (YOMJIW; Ren et al., 2019 ▸); R = 2-deoxy-β-d-erythro-pentofuranosyl, R1 = NH2, R2 = Br (HIPPAX; Seela et al., 1999 ▸), R2 = I (HIPPEB; Seela et al., 1999 ▸); R = 2-deoxy-2-fluoro-β-d-arabinofuranosyl, R1= NH2, R2= Br (EJEJUY; He et al., 2003 ▸). Analysis of the molecular geometries revealed that while the pyrazolopyrimidine unit remained essentially planar as in the molecule of (I), the diversity of substituents in these related structures and the presence of additional hydrogen bonding results in distinctly different crystal packings.
Figure 11.
Scheme used for the database search.
8. Synthesis and crystallization
A catalytic amount of tetra-n-butylammonium bromide (0.33 mmol) was added to a solution of 1-benzyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thione (10 mmol), iodomethane (10 mmol) and potassium carbonate (6.51 mmol) in dimethylformamide (DMF, 40 ml). The mixture was stirred for 24 h. The solid material was removed by filtration and the solvent evaporated in vacuo. The resulting colourless solid product was purified by recrystallization from ethanol. Yield: 82%.
9. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. Hydrogen atoms were located in difference-Fourier maps and were refined freely.
Table 2. Experimental details.
| Crystal data | |
| Chemical formula | C13H12N4S |
| M r | 256.33 |
| Crystal system, space group | Monoclinic, P21/c |
| Temperature (K) | 150 |
| a, b, c (Å) | 12.4617 (5), 7.0766 (3), 13.6500 (5) |
| β (°) | 96.085 (1) |
| V (Å3) | 1196.96 (8) |
| Z | 4 |
| Radiation type | Cu Kα |
| μ (mm−1) | 2.29 |
| Crystal size (mm) | 0.26 × 0.22 × 0.16 |
| Data collection | |
| Diffractometer | Bruker D8 VENTURE PHOTON 100 CMOS |
| Absorption correction | Multi-scan (SADABS; Krause et al., 2015 ▸) |
| Tmin, Tmax | 0.59, 0.72 |
| No. of measured, independent and observed [I > 2σ(I)] reflections | 8877, 2388, 2292 |
| R int | 0.026 |
| (sin θ/λ)max (Å−1) | 0.626 |
| Refinement | |
| R[F2 > 2σ(F2)], wR(F2), S | 0.049, 0.135, 1.10 |
| No. of reflections | 2388 |
| No. of parameters | 212 |
| H-atom treatment | All H-atom parameters refined |
| Δρmax, Δρmin (e Å−3) | 0.68, −0.42 |
Supplementary Material
Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989024005954/wm5721sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989024005954/wm5721Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989024005954/wm5721Isup3.cdx
Supporting information file. DOI: 10.1107/S2056989024005954/wm5721Isup4.cml
CCDC reference: 2363971
Additional supporting information: crystallographic information; 3D view; checkCIF report
supplementary crystallographic information
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Crystal data
| C13H12N4S | F(000) = 536 |
| Mr = 256.33 | Dx = 1.422 Mg m−3 |
| Monoclinic, P21/c | Cu Kα radiation, λ = 1.54178 Å |
| a = 12.4617 (5) Å | Cell parameters from 7875 reflections |
| b = 7.0766 (3) Å | θ = 6.3–74.7° |
| c = 13.6500 (5) Å | µ = 2.29 mm−1 |
| β = 96.085 (1)° | T = 150 K |
| V = 1196.96 (8) Å3 | Block, colourless |
| Z = 4 | 0.26 × 0.22 × 0.16 mm |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Data collection
| Bruker D8 VENTURE PHOTON 100 CMOS diffractometer | 2388 independent reflections |
| Radiation source: INCOATEC IµS micro–focus source | 2292 reflections with I > 2σ(I) |
| Mirror monochromator | Rint = 0.026 |
| Detector resolution: 10.4167 pixels mm-1 | θmax = 74.7°, θmin = 6.5° |
| ω scans | h = −15→14 |
| Absorption correction: multi-scan (SADABS; Krause et al., 2015) | k = −8→8 |
| Tmin = 0.59, Tmax = 0.72 | l = −15→17 |
| 8877 measured reflections |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Refinement
| Refinement on F2 | Secondary atom site location: difference Fourier map |
| Least-squares matrix: full | Hydrogen site location: difference Fourier map |
| R[F2 > 2σ(F2)] = 0.049 | All H-atom parameters refined |
| wR(F2) = 0.135 | w = 1/[σ2(Fo2) + (0.0792P)2 + 0.9126P] where P = (Fo2 + 2Fc2)/3 |
| S = 1.10 | (Δ/σ)max = 0.001 |
| 2388 reflections | Δρmax = 0.68 e Å−3 |
| 212 parameters | Δρmin = −0.42 e Å−3 |
| 0 restraints | Extinction correction: SHELXL2018/3 (Sheldrick, 2015b), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
| Primary atom site location: dual | Extinction coefficient: 0.0175 (15) |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Special details
| Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
| Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| S1 | 0.65190 (4) | 0.56176 (7) | 0.63280 (4) | 0.0270 (2) | |
| N1 | 0.60237 (13) | 0.1966 (2) | 0.62462 (13) | 0.0254 (4) | |
| N2 | 0.42503 (15) | 0.0580 (2) | 0.61920 (13) | 0.0250 (4) | |
| N3 | 0.28464 (13) | 0.2921 (2) | 0.62089 (12) | 0.0236 (4) | |
| N4 | 0.27715 (14) | 0.4851 (3) | 0.62427 (13) | 0.0262 (4) | |
| C1 | 0.56283 (15) | 0.3718 (3) | 0.62822 (13) | 0.0202 (4) | |
| C2 | 0.53049 (18) | 0.0519 (3) | 0.62047 (17) | 0.0286 (5) | |
| H2 | 0.561 (2) | −0.074 (4) | 0.618 (2) | 0.040 (8)* | |
| C3 | 0.38820 (15) | 0.2371 (3) | 0.62210 (13) | 0.0217 (4) | |
| C4 | 0.37631 (17) | 0.5524 (3) | 0.62805 (15) | 0.0250 (4) | |
| H4 | 0.3872 (18) | 0.676 (4) | 0.6326 (16) | 0.016 (5)* | |
| C5 | 0.45191 (16) | 0.4014 (3) | 0.62684 (14) | 0.0213 (4) | |
| C6 | 0.18860 (16) | 0.1711 (3) | 0.61404 (14) | 0.0254 (4) | |
| H6A | 0.213 (2) | 0.050 (4) | 0.6369 (18) | 0.024 (6)* | |
| H6B | 0.144 (2) | 0.215 (4) | 0.6594 (18) | 0.024 (6)* | |
| C7 | 0.13101 (14) | 0.1627 (3) | 0.51110 (13) | 0.0204 (4) | |
| C8 | 0.17719 (16) | 0.0661 (3) | 0.43709 (15) | 0.0232 (4) | |
| H8 | 0.242 (2) | 0.004 (4) | 0.4507 (16) | 0.021 (5)* | |
| C9 | 0.12422 (18) | 0.0575 (3) | 0.34245 (16) | 0.0271 (5) | |
| H9 | 0.156 (2) | −0.003 (4) | 0.295 (2) | 0.038 (7)* | |
| C10 | 0.02500 (17) | 0.1456 (3) | 0.32115 (16) | 0.0293 (5) | |
| H10 | −0.004 (2) | 0.137 (4) | 0.264 (2) | 0.041 (8)* | |
| C11 | −0.02157 (16) | 0.2423 (3) | 0.39411 (16) | 0.0290 (5) | |
| H11 | −0.082 (2) | 0.299 (4) | 0.3801 (19) | 0.033 (7)* | |
| C12 | 0.03167 (15) | 0.2506 (3) | 0.48894 (15) | 0.0245 (4) | |
| H12 | −0.003 (2) | 0.321 (4) | 0.538 (2) | 0.041 (7)* | |
| C13 | 0.77879 (19) | 0.4440 (3) | 0.6316 (2) | 0.0334 (5) | |
| H13A | 0.781 (2) | 0.381 (4) | 0.570 (2) | 0.040 (7)* | |
| H13B | 0.787 (2) | 0.361 (4) | 0.686 (2) | 0.036 (7)* | |
| H13C | 0.836 (3) | 0.547 (5) | 0.633 (3) | 0.068 (11)* |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| S1 | 0.0236 (3) | 0.0230 (3) | 0.0341 (3) | 0.00000 (17) | 0.0021 (2) | −0.00033 (17) |
| N1 | 0.0225 (8) | 0.0211 (8) | 0.0327 (9) | 0.0011 (6) | 0.0039 (7) | 0.0009 (6) |
| N2 | 0.0259 (9) | 0.0198 (8) | 0.0295 (9) | −0.0009 (6) | 0.0042 (7) | −0.0002 (6) |
| N3 | 0.0194 (8) | 0.0252 (9) | 0.0260 (8) | −0.0017 (6) | 0.0021 (6) | −0.0013 (6) |
| N4 | 0.0242 (9) | 0.0251 (9) | 0.0293 (8) | 0.0022 (7) | 0.0024 (6) | −0.0034 (7) |
| C1 | 0.0211 (9) | 0.0214 (9) | 0.0178 (8) | −0.0022 (7) | 0.0006 (6) | 0.0010 (7) |
| C2 | 0.0281 (11) | 0.0191 (10) | 0.0387 (12) | 0.0024 (8) | 0.0039 (9) | −0.0011 (8) |
| C3 | 0.0214 (9) | 0.0242 (10) | 0.0194 (8) | −0.0034 (7) | 0.0018 (7) | −0.0006 (7) |
| C4 | 0.0227 (10) | 0.0242 (11) | 0.0281 (10) | 0.0038 (7) | 0.0023 (8) | −0.0031 (7) |
| C5 | 0.0224 (10) | 0.0197 (9) | 0.0216 (9) | −0.0003 (7) | 0.0012 (7) | −0.0016 (7) |
| C6 | 0.0201 (9) | 0.0320 (11) | 0.0246 (9) | −0.0067 (8) | 0.0045 (8) | 0.0002 (8) |
| C7 | 0.0161 (8) | 0.0200 (8) | 0.0255 (9) | −0.0029 (7) | 0.0036 (7) | 0.0010 (7) |
| C8 | 0.0190 (10) | 0.0216 (9) | 0.0294 (10) | 0.0004 (7) | 0.0047 (8) | 0.0002 (7) |
| C9 | 0.0302 (11) | 0.0250 (10) | 0.0272 (10) | −0.0050 (8) | 0.0076 (8) | −0.0037 (7) |
| C10 | 0.0265 (10) | 0.0329 (11) | 0.0273 (10) | −0.0099 (8) | −0.0036 (8) | 0.0048 (8) |
| C11 | 0.0164 (9) | 0.0299 (11) | 0.0400 (11) | −0.0013 (8) | −0.0008 (8) | 0.0082 (9) |
| C12 | 0.0187 (9) | 0.0219 (9) | 0.0337 (10) | −0.0012 (7) | 0.0066 (7) | 0.0002 (7) |
| C13 | 0.0256 (11) | 0.0296 (12) | 0.0441 (13) | −0.0020 (8) | −0.0003 (9) | 0.0039 (9) |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Geometric parameters (Å, º)
| S1—C1 | 1.7400 (19) | C6—H6A | 0.95 (3) |
| S1—C13 | 1.789 (2) | C6—H6B | 0.93 (3) |
| N1—C1 | 1.337 (3) | C7—C12 | 1.390 (3) |
| N1—C2 | 1.358 (3) | C7—C8 | 1.394 (3) |
| N2—C2 | 1.313 (3) | C8—C9 | 1.388 (3) |
| N2—C3 | 1.350 (3) | C8—H8 | 0.91 (2) |
| N3—C3 | 1.346 (3) | C9—C10 | 1.388 (3) |
| N3—N4 | 1.370 (2) | C9—H9 | 0.90 (3) |
| N3—C6 | 1.466 (2) | C10—C11 | 1.385 (3) |
| N4—C4 | 1.320 (3) | C10—H10 | 0.83 (3) |
| C1—C5 | 1.396 (3) | C11—C12 | 1.392 (3) |
| C2—H2 | 0.97 (3) | C11—H11 | 0.86 (3) |
| C3—C5 | 1.406 (3) | C12—H12 | 0.97 (3) |
| C4—C5 | 1.426 (3) | C13—H13A | 0.96 (3) |
| C4—H4 | 0.89 (2) | C13—H13B | 0.95 (3) |
| C6—C7 | 1.510 (3) | C13—H13C | 1.02 (4) |
| C1—S1—C13 | 101.59 (10) | C7—C6—H6B | 111.9 (15) |
| C1—N1—C2 | 117.19 (17) | H6A—C6—H6B | 106 (2) |
| C2—N2—C3 | 111.93 (17) | C12—C7—C8 | 119.25 (18) |
| C3—N3—N4 | 110.87 (16) | C12—C7—C6 | 120.62 (17) |
| C3—N3—C6 | 127.36 (18) | C8—C7—C6 | 120.13 (17) |
| N4—N3—C6 | 121.74 (16) | C9—C8—C7 | 120.25 (19) |
| C4—N4—N3 | 107.11 (16) | C9—C8—H8 | 119.2 (14) |
| N1—C1—C5 | 120.45 (17) | C7—C8—H8 | 120.5 (14) |
| N1—C1—S1 | 118.78 (15) | C10—C9—C8 | 120.03 (19) |
| C5—C1—S1 | 120.76 (15) | C10—C9—H9 | 121.0 (18) |
| N2—C2—N1 | 129.09 (19) | C8—C9—H9 | 119.0 (18) |
| N2—C2—H2 | 115.3 (18) | C11—C10—C9 | 120.2 (2) |
| N1—C2—H2 | 115.6 (18) | C11—C10—H10 | 123 (2) |
| N3—C3—N2 | 126.83 (18) | C9—C10—H10 | 117 (2) |
| N3—C3—C5 | 107.31 (18) | C10—C11—C12 | 119.65 (19) |
| N2—C3—C5 | 125.86 (18) | C10—C11—H11 | 119.8 (18) |
| N4—C4—C5 | 110.24 (18) | C12—C11—H11 | 120.5 (18) |
| N4—C4—H4 | 119.6 (15) | C7—C12—C11 | 120.61 (19) |
| C5—C4—H4 | 130.1 (15) | C7—C12—H12 | 121.6 (17) |
| C1—C5—C3 | 115.47 (18) | C11—C12—H12 | 117.8 (17) |
| C1—C5—C4 | 140.06 (19) | S1—C13—H13A | 109.4 (17) |
| C3—C5—C4 | 104.47 (17) | S1—C13—H13B | 107.5 (17) |
| N3—C6—C7 | 112.75 (15) | H13A—C13—H13B | 113 (3) |
| N3—C6—H6A | 105.8 (16) | S1—C13—H13C | 106 (2) |
| C7—C6—H6A | 112.1 (15) | H13A—C13—H13C | 105 (3) |
| N3—C6—H6B | 107.8 (15) | H13B—C13—H13C | 115 (3) |
| C3—N3—N4—C4 | −0.3 (2) | N3—C3—C5—C1 | −179.69 (16) |
| C6—N3—N4—C4 | −178.65 (17) | N2—C3—C5—C1 | 0.2 (3) |
| C2—N1—C1—C5 | −0.5 (3) | N3—C3—C5—C4 | −0.1 (2) |
| C2—N1—C1—S1 | −179.60 (15) | N2—C3—C5—C4 | 179.84 (18) |
| C13—S1—C1—N1 | −0.32 (18) | N4—C4—C5—C1 | 179.4 (2) |
| C13—S1—C1—C5 | −179.38 (17) | N4—C4—C5—C3 | −0.1 (2) |
| C3—N2—C2—N1 | 0.3 (3) | C3—N3—C6—C7 | −99.9 (2) |
| C1—N1—C2—N2 | 0.2 (3) | N4—N3—C6—C7 | 78.2 (2) |
| N4—N3—C3—N2 | −179.71 (18) | N3—C6—C7—C12 | −108.9 (2) |
| C6—N3—C3—N2 | −1.4 (3) | N3—C6—C7—C8 | 71.1 (2) |
| N4—N3—C3—C5 | 0.2 (2) | C12—C7—C8—C9 | −0.2 (3) |
| C6—N3—C3—C5 | 178.49 (16) | C6—C7—C8—C9 | 179.77 (18) |
| C2—N2—C3—N3 | 179.36 (19) | C7—C8—C9—C10 | 0.1 (3) |
| C2—N2—C3—C5 | −0.6 (3) | C8—C9—C10—C11 | 0.0 (3) |
| N3—N4—C4—C5 | 0.2 (2) | C9—C10—C11—C12 | 0.0 (3) |
| N1—C1—C5—C3 | 0.3 (3) | C8—C7—C12—C11 | 0.2 (3) |
| S1—C1—C5—C3 | 179.39 (13) | C6—C7—C12—C11 | −179.80 (18) |
| N1—C1—C5—C4 | −179.1 (2) | C10—C11—C12—C7 | −0.1 (3) |
| S1—C1—C5—C4 | 0.0 (3) |
1-Benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine . Hydrogen-bond geometry (Å, º)
Cg3 is the centroid of the C7–C12 phenyl ring.
| D—H···A | D—H | H···A | D···A | D—H···A |
| C2—H2···S1i | 0.97 (3) | 2.81 (3) | 3.781 (2) | 174 (2) |
| C13—H13C···Cg3ii | 1.02 (4) | 2.49 (4) | 3.455 (2) | 157 (3) |
Symmetry codes: (i) x, y−1, z; (ii) −x+1, −y+1, −z+1.
Funding Statement
This work was funded by National Science Foundation grant 1228232; Tulane University ; Hacettepe University Scientific Research Project Unit grant 013 D04 602 004.
References
- Anderson, J. D., Dalley, N. K., Revankar, G. R. & Robins, R. K. (1986). J. Heterocycl. Chem.23, 1869–1878.
- Avasthi, K., Rawat, D. S., Sarkhel, S. & Maulik, P. R. (2002). Acta Cryst. C58, o325–o327. [DOI] [PubMed]
- Bakavoli, M., Bagherzadeh, G., Vaseghifar, M., Shiri, A., Pordel, M., Mashreghi, M., Pordeli, P. & Araghi, M. (2010). Eur. J. Med. Chem.45, 647–650. [DOI] [PubMed]
- Brandenburg, K. & Putz, H. (2012). DIAMOND, Crystal Impact GbR, Bonn, Germany.
- Bruker (2016). APEX3 and SAINT. Bruker AXS, Inc., Madison, Wisconsin, USA.
- El-Mekabaty, A. (2015). Chem. Heterocycl. Compd, 50, 1698–1706.
- El-Tombary, A. A. (2013). Sci. Pharm.81, 393–422. [DOI] [PMC free article] [PubMed]
- Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
- Gudmundsson, K. S., Johns, B. A. & Weatherhead, J. (2009). Bioorg. Med. Chem. Lett.19, 5689–5692. [DOI] [PubMed]
- Hathwar, V. R., Sist, M., Jørgensen, M. R. V., Mamakhel, A. H., Wang, X., Hoffmann, C. M., Sugimoto, K., Overgaard, J. & Iversen, B. B. (2015). IUCrJ, 2, 563–574. [DOI] [PMC free article] [PubMed]
- He, J., Eickmeier, H. & Seela, F. (2003). Acta Cryst. C59, o406–o408. [DOI] [PubMed]
- Hirshfeld, H. L. (1977). Theor. Chim. Acta, 44, 129–138.
- Irrou, E., Elmachkouri, Y. A., Oubella, A., Ouchtak, H., Dalbouha, S., Mague, J. T., Hökelek, T., El Ghayati, L., Sebbar, N. K. & Taha, M. L. (2022). Acta Cryst. E78, 953–960. [DOI] [PMC free article] [PubMed]
- Jayatilaka, D., Grimwood, D. J., Lee, A., Lemay, A., Russel, A. J., Taylor, C., Wolff, S. K., Cassam-Chenai, P. & Whitton, A. (2005). TONTO - A System for Computational Chemistry. Available at: http://hirshfeldsurface.net/
- Kandeel, M. M., Mohamed, L. W., Abd El Hamid, M. K. & Negmeldin, A. T. (2012). Sci. Pharm.80, 531–545. [DOI] [PMC free article] [PubMed]
- Khazi, M. I. A., Fathima, N., Belavagi, N. S., Begum, N. S. & Khazi, I. M. (2012). Acta Cryst. E68, o2083. [DOI] [PMC free article] [PubMed]
- Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
- Liu, M.-X., Li, J. R., Zheng, K., Yao, H., Zhang, Q. & Shi, D.-X. (2015). Tetrahedron, 71, 7658–7662.
- Mackenzie, C. F., Spackman, P. R., Jayatilaka, D. & Spackman, M. A. (2017). IUCrJ, 4, 575–587. [DOI] [PMC free article] [PubMed]
- Maher, M., Kassab, A. E., Zaher, A. F. & Mahmoud, Z. (2019). J. Enzyme Inhib. Med. Chem.34, 532–546. [DOI] [PMC free article] [PubMed]
- McKinnon, J. J., Jayatilaka, D. & Spackman, M. A. (2007). Chem. Commun. pp. 3814–3816. [DOI] [PubMed]
- Ren, H., An, H. & Tao, J. (2019). Molecules, 24, 983. [DOI] [PMC free article] [PubMed]
- Sebbar, N. K., Mekhzoum, M. E. M., Essassi, E. M., Zerzouf, A., Talbaoui, A., Bakri, Y., Saadi, M. & Ammari, L. E. (2016). Res. Chem. Intermed.42, 6845–6862.
- Seela, F., Becher, G., Rosemeyer, H., Reuter, H., Kastner, G. & Mikhailopulo, I. A. (1999). Helv. Chim. Acta, 82, 105–124.
- Severina, A., Georgiyants, V. A., Shtrygol, S. Y. & Kavraiskyi, D. P. (2016). Scr. Sci. Pharm.3, 36–40.
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
- Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
- Song, X. J., Shao, Y. & Dong, X. G. (2011). Chin. Chem. Lett.22, 1036–1038.
- Spackman, M. A. & Jayatilaka, D. (2009). CrystEngComm, 11, 19–32.
- Spackman, M. A., McKinnon, J. J. & Jayatilaka, D. (2008). CrystEngComm, 10, 377–388.
- Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst.54, 1006–1011. [DOI] [PMC free article] [PubMed]
- Tan, T. M. C., Yang, F., Fu, H., Raghavendra, M. S. & Lam, Y. (2007). J. Comb. Chem.9, 210–218. [DOI] [PubMed]
- Turner, M. J., Grabowsky, S., Jayatilaka, D. & Spackman, M. A. (2014). J. Phys. Chem. Lett.5, 4249–4255. [DOI] [PubMed]
- Turner, M. J., McKinnon, J. J., Jayatilaka, D. & Spackman, M. A. (2011). CrystEngComm, 13, 1804–1813.
- Turner, M. J., Thomas, S. P., Shi, M. W., Jayatilaka, D. & Spackman, M. A. (2015). Chem. Commun.51, 3735–3738. [DOI] [PubMed]
- Venkatesan, P., Thamotharan, S., Ilangovan, A., Liang, H. & Sundius, T. (2016). Spectrochim. Acta A Mol. Biomol. Spectrosc.153, 625–636. [DOI] [PubMed]
- Zhang, C., Zhou, Q., Wu, X. N., Huang, Y. D., Zhou, J., Lai, Z., Wu, Y. & Luo, H. B. (2018). J. Enzyme Inhib. Med. Chem.33, 260–270. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989024005954/wm5721sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989024005954/wm5721Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989024005954/wm5721Isup3.cdx
Supporting information file. DOI: 10.1107/S2056989024005954/wm5721Isup4.cml
CCDC reference: 2363971
Additional supporting information: crystallographic information; 3D view; checkCIF report











